These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 26327132)

  • 1. Incidence of Esophageal Adenocarcinoma and Causes of Mortality After Radiofrequency Ablation of Barrett's Esophagus.
    Wolf WA; Pasricha S; Cotton C; Li N; Triadafilopoulos G; Muthusamy VR; Chmielewski GW; Corbett FS; Camara DS; Lightdale CJ; Wolfsen H; Chang KJ; Overholt BF; Pruitt RE; Ertan A; Komanduri S; Infantolino A; Rothstein RI; Shaheen NJ
    Gastroenterology; 2015 Dec; 149(7):1752-1761.e1. PubMed ID: 26327132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiofrequency Ablation Is Associated With Decreased Neoplastic Progression in Patients With Barrett's Esophagus and Confirmed Low-Grade Dysplasia.
    Small AJ; Araujo JL; Leggett CL; Mendelson AH; Agarwalla A; Abrams JA; Lightdale CJ; Wang TC; Iyer PG; Wang KK; Rustgi AK; Ginsberg GG; Forde KA; Gimotty PA; Lewis JD; Falk GW; Bewtra M
    Gastroenterology; 2015 Sep; 149(3):567-76.e3; quiz e13-4. PubMed ID: 25917785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia.
    Parasa S; Vennalaganti S; Gaddam S; Vennalaganti P; Young P; Gupta N; Thota P; Cash B; Mathur S; Sampliner R; Moawad F; Lieberman D; Bansal A; Kennedy KF; Vargo J; Falk G; Spaander M; Bruno M; Sharma P
    Gastroenterology; 2018 Apr; 154(5):1282-1289.e2. PubMed ID: 29273452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost effectiveness of radiofrequency ablation for Barrett's esophagus.
    Hur C; Choi SE; Rubenstein JH; Kong CY; Nishioka NS; Provenzale DT; Inadomi JM
    Gastroenterology; 2012 Sep; 143(3):567-575. PubMed ID: 22626608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between length of Barrett's esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia.
    Anaparthy R; Gaddam S; Kanakadandi V; Alsop BR; Gupta N; Higbee AD; Wani SB; Singh M; Rastogi A; Bansal A; Cash BD; Young PE; Lieberman DA; Falk GW; Vargo JJ; Thota P; Sampliner RE; Sharma P
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1430-6. PubMed ID: 23707463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus.
    Wani S; Falk GW; Post J; Yerian L; Hall M; Wang A; Gupta N; Gaddam S; Singh M; Singh V; Chuang KY; Boolchand V; Gavini H; Kuczynski J; Sud P; Bansal A; Rastogi A; Mathur SC; Young P; Cash B; Goldblum J; Lieberman DA; Sampliner RE; Sharma P
    Gastroenterology; 2011 Oct; 141(4):1179-86, 1186.e1. PubMed ID: 21723218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency ablation and endoscopic mucosal resection for dysplastic barrett's esophagus and early esophageal adenocarcinoma: outcomes of the UK National Halo RFA Registry.
    Haidry RJ; Dunn JM; Butt MA; Burnell MG; Gupta A; Green S; Miah H; Smart HL; Bhandari P; Smith LA; Willert R; Fullarton G; Morris J; Di Pietro M; Gordon C; Penman I; Barr H; Patel P; Boger P; Kapoor N; Mahon B; Hoare J; Narayanasamy R; O'Toole D; Cheong E; Direkze NC; Ang Y; Novelli M; Banks MR; Lovat LB
    Gastroenterology; 2013 Jul; 145(1):87-95. PubMed ID: 23542069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Evidence-Based Surveillance Intervals After Radiofrequency Ablation of Barrett's Esophagus.
    Cotton CC; Haidry R; Thrift AP; Lovat L; Shaheen NJ
    Gastroenterology; 2018 Aug; 155(2):316-326.e6. PubMed ID: 29655833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of malignant progression in Barrett's esophagus indefinite for dysplasia.
    Ma M; Shroff S; Feldman M; DeMarshall M; Price C; Tierney A; Falk GW
    Dis Esophagus; 2017 Mar; 30(3):1-5. PubMed ID: 28184470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of nondysplastic Barrett's esophagus identifies patients at lower risk for esophageal adenocarcinoma: results from a large multicenter cohort.
    Gaddam S; Singh M; Balasubramanian G; Thota P; Gupta N; Wani S; Higbee AD; Mathur SC; Horwhat JD; Rastogi A; Young PE; Cash BD; Bansal A; Vargo JJ; Falk GW; Lieberman DA; Sampliner RE; Sharma P
    Gastroenterology; 2013 Sep; 145(3):548-53.e1. PubMed ID: 23714382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing outcome of radiofrequency ablation in Barrett's with high grade dysplasia and intramucosal carcinoma: a prospective multicenter UK registry.
    Haidry RJ; Lipman G; Banks MR; Butt MA; Sehgal V; Graham D; Dunn JM; Gupta A; Sweis R; Miah H; Morris D; Smart HL; Bhandari P; Willert R; Fullarton G; Morris J; Di Pietro M; Gordon C; Penman I; Barr H; Patel P; Boger P; Kapoor N; Mahon B; Hoare J; Narayanasamy R; O'Toole D; Cheong E; Direkze NC; Ang Y; Veitch A; Dhar A; Nyalender D; Ragunath K; Leahy A; Fullard M; Rodriguez-Justo M; Novelli M; Lovat LB
    Endoscopy; 2015 Nov; 47(11):980-7. PubMed ID: 26126159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of Esophageal Adenocarcinoma, Mortality, and Esophagectomy in Barrett's Esophagus Patients Undergoing Endoscopic Eradication Therapy.
    Smith ZL; Thorgerson AM; Dawson AZ; Wani S
    Dig Dis Sci; 2023 Dec; 68(12):4439-4448. PubMed ID: 37863992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal metaplasia recurs infrequently in patients successfully treated for Barrett's esophagus with radiofrequency ablation.
    Orman ES; Kim HP; Bulsiewicz WJ; Cotton CC; Dellon ES; Spacek MB; Chen X; Madanick RD; Pasricha S; Shaheen NJ
    Am J Gastroenterol; 2013 Feb; 108(2):187-95; quiz 196. PubMed ID: 23247578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease Progression in Barrett's Low-Grade Dysplasia With Radiofrequency Ablation Compared With Surveillance: Systematic Review and Meta-Analysis.
    Qumseya BJ; Wani S; Gendy S; Harnke B; Bergman JJ; Wolfsen H
    Am J Gastroenterol; 2017 Jun; 112(6):849-865. PubMed ID: 28374819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing prevalence of high-grade dysplasia and adenocarcinoma on index endoscopy in Barrett's esophagus over the past 2 decades: data from a multicenter U.S. consortium.
    Desai M; Lieberman DA; Kennedy KF; Hamade N; Thota P; Parasa S; Gorrepati VS; Bansal A; Gupta N; Gaddam S; Young PE; Mathur S; Moawad FJ; Cash BD; Sampliner R; Vargo JJ; Falk GW; Sharma P
    Gastrointest Endosc; 2019 Feb; 89(2):257-263.e3. PubMed ID: 30342028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eliminating a need for esophagectomy: endoscopic treatment of Barrett esophagus with early esophageal neoplasia.
    Lada MJ; Watson TJ; Shakoor A; Nieman DR; Han M; Tschoner A; Peyre CG; Jones CE; Peters JH
    Semin Thorac Cardiovasc Surg; 2014; 26(4):274-84. PubMed ID: 25837538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma.
    Wani S; Falk G; Hall M; Gaddam S; Wang A; Gupta N; Singh M; Singh V; Chuang KY; Boolchand V; Gavini H; Kuczynski J; Sud P; Reddymasu S; Bansal A; Rastogi A; Mathur SC; Young P; Cash B; Lieberman DA; Sampliner RE; Sharma P
    Clin Gastroenterol Hepatol; 2011 Mar; 9(3):220-7; quiz e26. PubMed ID: 21115133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety outcomes of multimodal endoscopic eradication therapy in Barrett's esophagus-related neoplasia: a systematic review and pooled analysis.
    Desai M; Saligram S; Gupta N; Vennalaganti P; Bansal A; Choudhary A; Vennelaganti S; He J; Titi M; Maselli R; Qumseya B; Olyaee M; Waxman I; Repici A; Hassan C; Sharma P
    Gastrointest Endosc; 2017 Mar; 85(3):482-495.e4. PubMed ID: 27670227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum 25-Hydroxyvitamin D Levels and the Risk of Dysplasia and Esophageal Adenocarcinoma in Patients with Barrett's Esophagus.
    Thota PN; Kistangari G; Singh P; Cummings L; Hajifathalian K; Lopez R; Sanaka MR
    Dig Dis Sci; 2016 Jan; 61(1):247-54. PubMed ID: 26233550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the Learning Curve on Efficacy of Radiofrequency Ablation for Barrett's Esophagus.
    Pasricha S; Cotton C; Hathorn KE; Li N; Bulsiewicz WJ; Wolf WA; Muthusamy VR; Komanduri S; Wolfsen HC; Pruitt RE; Ertan A; Chmielewski GW; Shaheen NJ
    Gastroenterology; 2015 Oct; 149(4):890-6.e2. PubMed ID: 26116806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.